Pharmaceutical Glass Packaging Market Size (2024 - 2029)

The pharmaceutical glass packaging market is experiencing growth driven by the increasing demand for sustainable and effective packaging solutions for pharmaceutical products. Glass packaging is favored for its inert, impermeable, and recyclable properties, making it ideal for protecting medicines from damage and contamination. The rising need for injectable pharmaceuticals and the expansion of the pharmaceutical industry globally are significant factors contributing to the market's expansion. Despite challenges such as high raw material costs and competition from plastics, the market continues to grow, supported by the increased demand for medicines and vaccines following the COVID-19 pandemic.

Home Market Analysis Packaging Research Packaging Materials Research Glass Packaging Research Pharmaceutical Glass Packaging Industry Market Size

Market Size of Pharmaceutical Glass Packaging Industry

Pharmaceutical Glass Packaging Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 29.77 Billion
Market Size (2029) USD 38.52 Billion
CAGR (2024 - 2029) 5.29 %
Fastest Growing Market Asia-Pacific
Largest Market Asia-Pacific

Major Players

Pharmaceutical Glass Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Glass Packaging Market Analysis

The Pharmaceutical Glass Packaging Market size is estimated at USD 29.77 billion in 2024, and is expected to reach USD 38.52 billion by 2029, growing at a CAGR of 5.29% during the forecast period (2024-2029).

  • Glass packaging solutions are offered mainly as the primary packaging for pharmaceutical products and are among the leading packaging materials for the pharmaceutical industry. This is primarily due to advantages such as being sustainable, inert, impermeable, recyclable with no loss in quality, and reusable. Glass containers are among the primary packaging materials that have found significant use in the pharmaceutical industries.
  • The pharmaceutical industry is growing significantly worldwide, creating the need for packaging for communicable and non-communicable disease treatments. Thus, the demand for glass packaging in pharmaceutical manufacturing is increasing as it protects medicines from damage, biological contamination, and external influences.
  • Furthermore, the growing demand for injectable pharmaceuticals is propelling the growth of glass bottles in the pharmaceutical industry. The strong demand for oncology and other high-potency drugs (such as antibody conjugates and steroids with a fast onset of action) and growth in the per capita pharmaceutical spending are expected to be the primary growth drivers.
  • Over time, the market also faced challenges that included glass packaging getting expensive due to raw material prices and other factors, and it could not provide economically viable solutions for packaging products across mass consumption. That marked the advent of plastics as an option.
  • The COVID-19 pandemic has left a steady growth rate with increased demand for medicines. The surge in the need for pharmaceutical drugs during the pandemic has positively impacted the market’s growth. It is further expected to grow as new drugs and vaccines are being approved and phased out in different countries by pharmaceutical manufacturers, expanding the scope of glass packaging.

Pharmaceutical Glass Packaging Industry Segmentation

The pharmaceutical industry is rising significantly worldwide, creating the need for packaging for communicable and non-communicable disease treatments.

The pharmaceutical glass packaging market is segmented by product (bottles, vials, ampoules, and cartridges & syringes) and by geography ((North America [United States and Canada], Europe [Germany, United Kingdom, France, Italy, and Rest of Europe], Asia-Pacific [China, India, Japan, and Rest of Asia-Pacific], Latin America [Brazil, Argentina, and Rest of Latin America], Middle East and Africa [Saudi Arabia, South Africa, and Rest of Middle East and Africa]). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.

By Product
Bottles
Vials
Ampoules
Cartridges and Syringes
Others Products
By Geography
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Pharmaceutical Glass Packaging Market Size Summary

The pharmaceutical glass packaging market is poised for significant growth, driven by the increasing demand for sustainable and reliable packaging solutions in the pharmaceutical industry. Glass packaging is favored for its inert, impermeable, and recyclable properties, making it an ideal choice for protecting medicines from damage and contamination. The rising demand for injectable pharmaceuticals, particularly in the oncology and high-potency drug sectors, is a key factor propelling market expansion. Despite challenges such as high raw material costs and competition from plastic packaging, the market continues to thrive, bolstered by the ongoing need for pharmaceutical products and the approval of new drugs and vaccines globally.

Emerging markets, particularly in Asia, are becoming increasingly important for the pharmaceutical glass packaging industry. Countries like China and India are experiencing rapid growth in their pharmaceutical sectors, driven by increased healthcare investments and a focus on generic and injectable drugs. The presence of multinational pharmaceutical companies in these regions further fuels demand for glass packaging. Additionally, strategic investments and partnerships, such as those by Gerresheimer AG and Corning Incorporated, are enhancing production capabilities and technological advancements in glass packaging. The market's competitive landscape is characterized by high rivalry, with major players actively pursuing expansion and innovation to meet the growing needs of the pharmaceutical industry.

Explore More

Pharmaceutical Glass Packaging Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Value Chain Analysis

    3. 1.3 Industry Attractiveness - Porter Five Forces

      1. 1.3.1 Bargaining Power of Suppliers

      2. 1.3.2 Bargaining Power of Buyers/Consumers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitutes

      5. 1.3.5 Intensity of Competitive Rivalry

    4. 1.4 Assessment of COVID-19 Impact on the Industry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Bottles

      2. 2.1.2 Vials

      3. 2.1.3 Ampoules

      4. 2.1.4 Cartridges and Syringes

      5. 2.1.5 Others Products

    2. 2.2 By Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Italy

        5. 2.2.2.5 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 India

        3. 2.2.3.3 Japan

        4. 2.2.3.4 Rest of Asia-Pacific

      4. 2.2.4 Latin America

        1. 2.2.4.1 Brazil

        2. 2.2.4.2 Argentina

        3. 2.2.4.3 Rest of Latin America

      5. 2.2.5 Middle East and Africa

        1. 2.2.5.1 Saudi Arabia

        2. 2.2.5.2 South Africa

        3. 2.2.5.3 Rest of Middle East and Africa

Pharmaceutical Glass Packaging Market Size FAQs

The Pharmaceutical Glass Packaging Market size is expected to reach USD 29.77 billion in 2024 and grow at a CAGR of 5.29% to reach USD 38.52 billion by 2029.

In 2024, the Pharmaceutical Glass Packaging Market size is expected to reach USD 29.77 billion.

Pharmaceutical Glass Packaging Market Report Snapshots

Pharmaceutical Glass Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)